Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.00
-1.10%
After-hours: Aug 15, 2025, 07:57 PM EDT
Axsome Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M | -34.88M | -32.28M | -29.26M |
Depreciation & Amortization | 1.71M | 1.72M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 1.38M | 1.98M | 2.02M | 1.96M | 1.27M | 311.7K | 307.41K | 299.74K | 277.42K | 271.09K |
Stock-Based Compensation | 24.61M | 23.31M | 21.99M | 21.66M | 21.38M | 20.19M | 18.91M | 14.84M | 15.92M | 12.94M | 10.77M | 9.2M | 10.16M | 7.6M | 5.89M | 5.73M | 5.46M | 3.73M |
Other Working Capital | n/a | -4.17M | 27.1M | -16.52M | 33.55M | -13.2M | 13.14M | 13.1M | 3.25M | 4.72M | 12.87M | 22.52M | 6.18M | -384.82K | -793.98K | 311.31K | 4.24M | -3.08M |
Other Non-Cash Items | -10.77M | -8.99M | 11.85M | 38.32M | 2.98M | 17.14M | 44.83M | 1.03M | 7.13M | 105K | 4.19M | 119.56K | -658.25K | 8.34K | -34.29K | 522.00 | -71.09K | 255.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -617K | n/a | 617K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | 12.8M | -16.07M | 22.88M | -6.81M | 3.42M | -8.96M | -13.23M | -9.63M | 16.7M | 10.78M | -2.87M | -939.03K | -1.03M | 2.08M | 1.23M | -1.96M |
Operating Cash Flow | -32.42M | -43.38M | -26.2M | -18.63M | -30.11M | -53.47M | -30.36M | -53.55M | -55.35M | -5.82M | -27.56M | -22.76M | -33.54M | -32.65M | -28.84M | -26.78M | -25.39M | -27.22M |
Capital Expenditures | n/a | n/a | -30K | 150K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -241.46K | -213.74K | 307.55K | -258.68K | -18.88K | -30K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -53M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -13K | -338K | n/a | -240K | n/a | -98K | -582K | n/a | n/a | -71K | -53,702.1B | n/a | n/a | -213.74B | -307.55B | n/a | n/a | -30B |
Investing Cash Flow | -13K | -338K | -30K | -90K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -53.24M | -213.74K | -307.55B | -258.68K | -18.88K | -30K |
Debt Repayment | n/a | -401K | -330K | -311K | -186K | -163K | n/a | n/a | 30M | 55M | n/a | n/a | 45M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -1.33M | -1.62M | -280K | n/a | n/a | -867K | -162.68K | n/a | n/a | n/a | -91.7K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.43M | 29.27M | -1.84M | 17.61M | 14.56M | -1.02M | -2K | -380K | -8.92M | -2.57M | 1.07M | -1.1M | -2.09M | -88.24K | 690.48K | 438.68K | 874.88K | 1.91M |
Financial Cash Flow | 34.54M | 29.27M | 14.24M | 30.41M | 14.38M | -1.19M | -2K | 33.37M | 246.08M | 51.56M | 1.07M | 176.95M | 75.46M | 31.1M | 690.48K | 438.68K | 1.97M | 8.03M |
Net Cash Flow | 2.11M | -14.44M | -11.99M | 11.68M | -15.78M | -54.75M | -30.37M | -20.55M | 190.6M | 45.67M | -26.68M | 154.13M | -11.31M | -1.77M | -28.15M | -26.6M | -23.44M | -19.22M |
Free Cash Flow | -32.42M | -43.38M | -26.23M | -18.48M | -30.16M | -53.56M | -30.37M | -53.92M | -55.48M | -5.89M | -27.74M | -22.82M | -33.78M | -32.87M | -28.53M | -27.03M | -25.41M | -27.25M |